Oral and injected BPC-157 should not be treated as interchangeable. A route changes the scientific question: what reaches the intended tissue, in what form, and with what measurable clinical effect? A claim that one route “works better” needs a direct comparison, not matching testimonials from unrelated people.
What the route research establishes
A pharmacokinetic study in rats and dogs examined exposure and metabolism after intravenous and intramuscular administration. It was not a human comparison of capsules with injections. FDA's 2026 BPC-157 evaluation reported no human pharmacokinetic data for several proposed routes, including oral and subcutaneous administration, in its search.
The important distinction is between detecting a substance and showing a patient benefit. An assay can measure a molecule without establishing a concentration that improves an injury. Conversely, a proposed local effect in the gut would require a different investigation from a claim about a distant tendon. Neither possibility supplies the missing clinical comparison.
Why absorption percentages need context
A useful absorption claim identifies the exact formulation, species, measurement method and comparator. Was the assay tracking intact BPC-157, a breakdown product, or a radioactive label? Was the formulation the same as the advertised product? An impressive percentage without those details cannot resolve the route question.
Personal sensations are not a substitute for these measurements. Feeling something after a capsule does not reveal how much intact peptide entered circulation. Feeling nothing does not establish that a product was inactive. Both interpretations skip the measurement needed to distinguish them.
What a meaningful comparison would look like
The informative study would assign comparable patients to clearly characterized formulations, measure relevant symptoms and function, and collect adverse events consistently. It would also explain what improvement counts as clinically worthwhile and how long it lasts.
Until such evidence addresses the intended condition, route choice cannot be settled from Reddit reports. This is a research comparison, not a recommendation to inject, swallow or change a prescribed medicine. A study involving one preparation also cannot authenticate a different catalog product.
